FindTrial
Sign In

To study the prevalence of von Willebrand disease in Udupi district

Study of prevalence of von Willebrand disease in Udupi district with validation of self-administered ISTH bleeding assessment tool and standardization of vWF:RCo assay in differentiating different types of von Willebrand disease - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069473
Enrollment
13000
Registered
2024-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Sowmya Nayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adolescent girls and young adult women as well as adolescent boys and young adult men. Aged between 14-25 years.

Exclusion criteria

Exclusion criteria: Aged more than 25 years of age. People who are taking antifibrinolytics or anticoagulants and have any medical conditions

Design outcomes

Primary

MeasureTime frame
Prevalence of von Willebrand disease among adolescent girls and young adult women in Udupi district.Timepoint: Two years and six months—

Secondary

MeasureTime frame
Cross-cultural validation of self-administered ISTH bleeding assessment tool (self-BAT) for screening bleeding disorders.Timepoint: Six months—

Countries

India

Contacts

Public ContactDr Sushma Belurkar

Kasturba Medical College, Manipal

sushma.b@manipal.edu9448888415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026